Vyepti offered for DKK 774m within the third quarter, in comparison with DKK 444m in Q3 of final 12 months.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/lundbeck-ceo-positive-about-potential-for-migraine-drug-in-china-after-strong-trial-data/
Lundbeck CEO positive about potential for migraine drug in China after strong trial data
赞 (0)
关于作者
Jefferies sees no major changes to Lundbeck’s estimates despite upward revision
上一篇
14 11 月, 2024 1:19 下午
ALK surprises positively in the third quarter
下一篇
14 11 月, 2024 1:19 下午
相关推荐
-
ERI Brings AI and Robotics Driven ITAD Services to California
FRESNO, Calif.–( ORGANIZATION CABLE)– #California– ERI, the country’s biggest completely incorporated IT and electronic devices possession personality (ITAD…
-
Samenvatting: SLB kondigt conference call voor resultaten derde kwartaal 2024 aan
HOUSTON–(BUSINESS WIRE)–SLB (NYSE: SLB) zal op 18 oktober 2024 een conference call houden om de resultaten voor het derde kwartaal eindigend op 30 september 2024 te bes…
-
Snowflake Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
No-Headquarters/BOZEMAN, Mont.–( COMPANY CABLE)– #snowflakesummit– Snow Inc. (NYSE: SNOW) (” Snow”), the AI Information Cloud Firm, today introduced t…
-
Google inks controversial deal with California’s lawmakers to fund local news
Google LLC and the state of The golden state have actually consented to an offer under which the technology titan will certainly dedicate $172.5 million to money neighborhood journ…
-
T-Mobile Crowns Inola High School Champion in Friday Night 5G Lights Competition
BELLEVUE, Wash.–( COMPANY CABLE)– The delay mores than! Today, T-Mobile (NASDAQ: TMUS) introduced the last champ of its Friday Evening 5G Lighting competitors: Inola Se…
